How Much Does Medical Device Development Cost? 9 Factors That Affect the Budget
Can You Tell Me How Much It Will Cost to Develop My Medical Device?
It is one of the first questions a founder asks.
And it is a completely reasonable one.
You have an idea. Perhaps there is already a sketch, CAD model or even an early prototype.
Before going further, you need to know:
How much money are we actually talking about?
The difficulty is that medical device development doesn't have a standard price tag.
Two products that look similar from the outside can require very different amounts of engineering.
A simple mechanical product with a few components is one development problem.
Add electronics, sensors, software, moving components or connectivity and the problem changes.
Add patient contact, sterilisation requirements, demanding environmental conditions or more extensive verification and validation needs, and it changes again.
Across 60+ healthcare product development projects at Inspire Design, we have seen another factor make a significant difference:
Where the product is when development begins.
A founder with an idea on paper needs something very different from a company with tested product requirements and a working prototype.
So when someone asks us:
“How much will my medical device cost to develop?”
We usually need to understand the product before we can give a useful answer.
Here are 9 factors that can change that budget considerably.
1. How Much of the Product Exists Today?
Let's start with two founders.
Founder A has an idea.
There is a clinical problem they understand well and a rough sketch of what the solution might look like.
Founder B has CAD files, defined product requirements and a functional prototype that has already gone through several iterations.
Both say:
“I need help developing a medical device.”
But they are not starting from the same place.
Founder A may still need work around the user need, product architecture, concept development, engineering feasibility and early prototyping.
Founder B may need engineering refinement, testing, Design for Manufacturing (DFM) and preparation for the next stage.
This is why a useful development estimate should begin with a current-state assessment.
What exists?
What has been tested?
Which assumptions have already been validated?
Which decisions are still open?
And, just as importantly, what needs to be delivered at the end of the engagement?
The cost of getting from idea → first prototype is a different question from getting from working prototype → manufacturing-ready design.
2. What Does the Device Actually Have to Do?
A medical device can look simple and still contain considerable engineering complexity.
Imagine two handheld devices of roughly the same size.
The first is primarily mechanical.
The second contains:
A sensor
Electronics
A battery
A display
Firmware
Wireless connectivity
A mechanical mechanism
An enclosure that has to package everything together
From the outside, both may look like handheld products.
From a development perspective, they are very different.
Every additional subsystem creates not only another piece of work but another interface that needs to function properly.
The enclosure needs to accommodate the electronics.
The battery influences space and thermal considerations.
The sensor needs to integrate with the product architecture.
Software and hardware have to interact.
This is one reason we don't estimate complexity by looking at the size of the product.
A smaller medical device isn't necessarily a simpler one.
FDA's current design-and-development material reflects how broad the inputs can become, including user needs, intended use, performance, physical characteristics, safety, human factors, reliability, manufacturing processes and other device-specific requirements.
The number of problems the product has to solve matters more than how large it looks on the table.
3. How Clear Are the Requirements?
This is one of the less obvious budget drivers.
Suppose the development brief says:
“The device should be lightweight, portable and easy to use.”
That is useful direction.
It isn't yet enough engineering information.
How lightweight?
What dimensions define portable?
Who is using it?
What does “easy” mean in the actual clinical workflow?
Does the device need to withstand a particular load?
How many operating cycles does it need to survive?
What environmental conditions matter?
The clearer these requirements become, the more focused design and engineering work can become.
When they remain vague, teams can spend time solving one interpretation of the
problem only to discover later that the requirement meant something else.
FDA's design-and-development framework similarly starts with defining inputs and requires outputs to meet those input requirements. Current FDA QMSR materials also state that design outputs should provide appropriate information for purchasing, manufacturing and servicing, contain or reference acceptance criteria, and specify characteristics essential for proper use and safety.
In practical terms:
Clarity early in development helps reduce expensive ambiguity later.
4. How Many Things Do We Still Need to Learn Through Prototyping?
This is where founders often ask another question:
Again, there isn't one useful number.
Because “prototype” can mean very different things.
One team may need a simple physical model to understand size and grip.
Another needs to prove that a mechanism works.
Another needs an integrated prototype containing mechanical parts and electronics.
Another may already be developing more production-representative prototypes.
The process can also be iterative.
Prototype 1 → Test → Learn → Change
Then:
Prototype 2 → Test → Learn → Change
The cost therefore depends not only on how expensive each prototype is, but on how much uncertainty needs to be resolved through physical iterations.
This is why we don't think the objective should be to minimise the number of prototypes at all costs.
A prototype that exposes a major problem early can be extremely valuable.
The expensive situation is often discovering that same problem much later.
Research outside the medical-device sector but across product/machine development has estimated that roughly 70–80% of product costs can be influenced during design and development. The exact percentage should not be treated as a universal medical-device figure, but the underlying lesson is relevant: early design decisions can have substantial downstream cost implications.
So the useful question isn't:
“How cheaply can we make this prototype?”
It is:
“What does this prototype need to teach us before we spend more?”
5. Who Needs to Use the Product-and Where?
Now imagine the device works perfectly on the engineering table.
Then it reaches a clinician.
They hold it differently.
They use it while wearing gloves.
They need to operate it with one hand.
They can't easily see the display from the position in which the device is actually used.
Or perhaps the device needs to work around other equipment in a crowded clinical environment.
Those observations can result in design changes.
And design changes mean engineering time, another prototype or further testing.
This isn't an argument against user testing.
It is exactly why understanding the user earlier can help development.
Medical-device design inputs can include user and patient needs, intended use, human factors and compatibility with the intended use environment, among other considerations.
The development budget therefore depends partly on the number and complexity of user interactions that need to be understood.
A product used by a trained clinician in one controlled setting presents a different development problem from a product intended for multiple user groups and environments.
6. What Testing Will the Device Need?
This can change the budget significantly.
Developing a device and demonstrating that it meets its defined requirements are not the same activity.
Depending on the device and market, development may involve different forms of engineering evaluation, verification, validation and specialist testing.
That could involve areas such as:
Mechanical performance
Durability
Electrical considerations
Environmental testing
Biocompatibility where applicable
Usability/human factors
Software-related testing
Packaging
Sterilisation where relevant
Not every device needs every test on that list.
That's exactly the point.
The device, intended use, risk, applicable requirements and target market determine what needs to be established.
For devices subject to the relevant U.S. requirements, FDA's design-control framework includes identifying requirements, risk analysis, design verification, design validation and transfer into production specifications.
Testing can therefore affect the budget in two ways.
There is the cost of the testing itself.
Then there is what the test reveals.
A failed test can send the product back into engineering, redesign and another round of evaluation.
This is why testing should not be treated as a line item that appears only when the design is “finished.”
7. Are You Designing a Prototype-or a Product That Needs to Be Manufactured?
This is where development budgets can change direction.
A working prototype can often be built using processes chosen for speed and flexibility.
Manufacturing asks for something else.
Repeatability.
A 3D-printed enclosure may work perfectly during development.
If the intended production process later becomes injection moulding, the same enclosure may need another engineering review.
Wall thickness.
Draft.
Tooling.
Tolerances.
Material.
Assembly.
Expected production volume.
The product may look almost unchanged while significant work happens behind the surface.
This is Design for Manufacturing (DFM).
And the timing matters.
If manufacturing thinking begins while the design can still change, it can influence the product.
If it begins after everyone considers the design finished, the team may discover that parts of the product need to be revisited.
FDA's longstanding design-control guidance makes a similar lifecycle point: device design includes the associated manufacturing processes, and design controls extend through transfer to production and subsequent changes.
For us, DFM isn't simply another activity to add to the quotation.
It is one of the ways development decisions and eventual manufacturing economics become connected.
8. What Does Regulatory Readiness Require From the Design?
There is a common misconception that product development happens first and regulatory work happens afterwards.
In reality, the regulatory pathway can influence development much earlier.
The intended use can matter.
Device classification can matter.
The markets in which the company intends to launch can matter.
Testing requirements can matter.
Documentation can matter.
Risk-management activities can matter.
In the U.S., for example, FDA's Quality Management System Regulation (QMSR) became effective on February 2, 2026 and incorporates ISO 13485:2016 by reference as the foundational medical-device quality-management-system framework.
India has its own regulatory framework, and requirements differ by device and market.
The important budgeting lesson is not that every startup needs to spend heavily on regulatory work from Day 1.
It is that the team should understand the regulatory direction early enough that product decisions don't have to be unnecessarily reversed later.
At Inspire Design, we approach this from the product-development side: design,
engineering, prototyping and manufacturing readiness need to be developed with awareness of the requirements the product will eventually need to meet.
9. What Happens After the Prototype Works?
This is the budget line that is easiest to forget.
Suppose you've budgeted successfully for:
Concept development.
Engineering.
CAD.
Prototypes.
Testing.
And now the prototype works.
Are you finished?
Usually not.
If the goal is commercial production, the next stage may involve:
DFM/DFA
Production drawings and specifications
Production-intent materials
Supplier development
Tooling
Fixtures
Pilot builds
Manufacturing documentation
Inspection and acceptance requirements
Further verification or validation activities where required
FDA's current QMSR requires applicable manufacturers to establish and follow a quality-management system so finished devices consistently meet applicable requirements and specifications.
This is why we think “prototype cost” and “product-development cost” should not be used interchangeably.
A product ready to move towards commercial manufacturing is another.
If your budget stops at the first milestone while your business plan assumes the second, there is a gap.
So, How Much Does It Actually Cost to Develop a Medical Device?
The useful answer is:
It depends on what you are developing, where the product stands today and how far you need to take it.
A simple mechanical device and an electronically integrated device should not be expected to carry the same development budget.
Neither should:
Idea → Proof of Concept
and
Working Prototype → Manufacturing-Ready Design
Trying to publish one generic figure would therefore be misleading.
A more useful estimate starts by defining the scope.
Question | Why it affects budget |
How complex is it? | Determines how much development already exists |
Are requirements defined? | Influences design and engineering effort |
How much prototyping is needed? | Determines how much ambiguity remains |
Who will use it? | Influences fabrication and iteration |
What testing is required? | Influences usability/human-factors work |
How will it be manufactured? | Can add testing and redesign cycles |
What regulatory requirements apply? | Adds DFM/DFA and production engineering |
How far are we taking it? | Can influence design, testing and documentation |
How complex is it? | Prototype and manufacturing readiness are different scopes |
This is why the first conversation about cost should probably not start with:
“What's your price?”
It should start with:
“What exactly are we trying to get to?”
The ₹10 Lakh Question Isn't Always “Can We Reduce the Quote?”
Here's a simple hypothetical.
Suppose a development decision adds ₹100 to the eventual unit cost.
At 100 units, that's ₹10,000.
At 1,000 units, that's ₹1 lakh.
At 10,000 units, that's ₹10 lakh.
These are illustrative numbers, but the arithmetic explains an important point.
Sometimes spending more engineering effort to simplify a part, reconsider an assembly or choose a more appropriate manufacturing approach can make economic sense.
Sometimes it won't.
If redesign costs ₹5 lakh to save ₹10 on a product that will only ever sell 1,000 units, the economics look very different.
This is why development cost and manufacturing cost shouldn't always be optimised separately.
The cheapest development route is not necessarily the route that produces the most economical product.
And equally, spending more on engineering is not automatically better.
The decision depends on volume, product requirements and what the change actually achieves.
Where Should a Medical Device Startup Spend First?
If the budget is limited, our preference would not be to divide the money equally across every stage.
Spend first on reducing the biggest uncertainties.
If nobody knows whether the core mechanism works, test that before polishing the enclosure.
If clinicians haven't validated the fundamental workflow assumption, understand that before investing heavily in detailed engineering.
If the product works but nobody has considered how it will be manufactured, review that before committing to expensive production tooling.
This is where staged development can be useful.
Instead of asking:
“What will the entire product cost from idea to market?”
start with:
“What is the next milestone, and what do we need to establish before spending beyond it?”
That gives founders decision points.
And it gives the development team clearer objectives.
9 Questions to Answer Before Setting Your Medical Device Development Budget
Before asking for a quotation, try answering these:
1. What stage is the product at today?
2. What exactly needs to exist at the end of this development phase?
3. Which technical uncertainties remain unresolved?
4. How many subsystems need to be designed and integrated?
5. What do we need prototypes to establish?
6. Which user and testing requirements need to be addressed?
7. Do we understand the likely manufacturing approach?
8. Which regulatory/quality requirements could influence development?
9. Are we budgeting for a prototype-or for a product that can move towards manufacturing?
If several answers are still unclear, asking for a fixed development price may be premature.
The first useful exercise may be defining the development scope.
The Better Question Isn't “How Much Will My Medical Device Cost?”
It is:
“How much will it cost to get from where we are today to the next meaningful milestone?”
For one company, that milestone may be proving the mechanism.
For another, it is putting a functional prototype into clinicians' hands.
For another, it is taking an existing prototype through engineering refinement and Design for Manufacturing.
And for another, it is preparing a product for pilot production.
Across 60+ healthcare product development projects, we have found that defining that destination makes the budget conversation considerably more useful.
Because once the scope is clear, you can decide what needs to happen now, what can happen later and where the development budget is actually creating value.
Have a Medical Device Idea, CAD Model or Working Prototype?
If you're trying to understand what the next stage of development could involve-and what you should actually budget for-it helps to start with the product rather than a generic price range.
At Inspire Design, we work with clinicians, healthcare startups and medical-device companies across industrial design, engineering, prototyping and Design for Manufacturing.
Show us where the product stands today and where you need to take it. We can help define what needs to happen in between.
FAQs About Medical Device Development Cost
1. How much does it cost to develop a medical device?
There is no standard medical device development cost. The budget depends on factors including device complexity, current development stage, product requirements, engineering scope, number and type of prototypes, testing, intended users, manufacturing requirements and regulatory pathway.
2. Why can't a medical device development company give an immediate fixed price?
A useful estimate requires understanding what needs to be developed and what deliverables are expected. An idea requiring concept development and feasibility work has a different scope from a tested prototype requiring DFM and manufacturing preparation.
3. How much does a medical device prototype cost?
There is no universal prototype cost. A simple form model, functional mechanical prototype and integrated electronic prototype can require very different materials, processes, components and engineering effort.
4. What makes medical device development expensive?
Complexity increases when the product requires multiple engineering disciplines, specialised components, extensive prototyping, user evaluation, verification/validation, manufacturing engineering or other device-specific requirements.
5. Can prototyping reduce medical device development cost?
Prototyping can help identify design and engineering problems before later development stages. However, the value depends on whether each prototype is built to answer a clear question. Building repeated prototypes without defined learning objectives can also add unnecessary cost.
6. How can a startup control medical device development costs?
One approach is to develop in clearly defined stages, prioritise the largest technical/user uncertainties first, establish measurable requirements, use prototypes purposefully and introduce manufacturing considerations before the design becomes difficult to change.
7. Does Design for Manufacturing increase development cost?
DFM requires engineering effort during development, but it can also identify opportunities to simplify parts, assembly and production before manufacturing. Whether a specific DFM change is economically worthwhile depends on factors such as production volume, tooling, unit cost and product requirements.
Comments